Literature DB >> 14628881

Adrenal histoplasmosis: clinical presentation and imaging features in nine cases.

N Kumar1, S Singh, S Govil.   

Abstract

BACKGROUND: We describe a retrospective analysis of the clinical presentation and imaging features in nine patients with adrenal histoplasmosis in nonimmunocompromised patients from a nonendemic region.
METHODS: Clinically, a tuberculosis-like presentation in four patients and a tumor-like presentation in five patients were seen. All patients were seronegative for the human immunodeficiency virus. Ultrasound (US) in all patients, computed tomography (CT) in six, and magnetic resonance imaging (MRI) in three showed suprarenal masses. CT-guided (in five) and US-guided (in four) biopsy and fine-needle aspiration cytology established a definite diagnosis. The work-up for malignancy and tuberculosis was negative.
RESULTS: On cross-sectional imaging, eight patients had bilateral adrenal masses and one had a unilateral adrenal mass. Imaging features were variable. All adrenal masses were hypoechoic on US, homogeneous in five, and heterogeneous in four patients. All adrenal masses were hypodense on CT, homogeneous in four, and heterogeneous in two. Heterogeneous enhancement was seen in three, homogeneous enhancement in two, and no enhancement in one patient. MRI in three patients showed that the masses were of variable signal intensity on all pulse sequences.
CONCLUSION: Our case series showed that adrenal histoplasmosis does occur in immunocompetent persons living in areas not endemic for the disease. The imaging features were variable.

Entities:  

Mesh:

Year:  2003        PMID: 14628881     DOI: 10.1007/s00261-003-0010-5

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  11 in total

Review 1.  Adrenal hypofunction from histoplasmosis: a literature review from 1971 to 2012.

Authors:  R J Koene; J Catanese; G A Sarosi
Journal:  Infection       Date:  2013-06-15       Impact factor: 3.553

Review 2.  A Twenty-First-Century Perspective of Disseminated Histoplasmosis in India: Literature Review and Retrospective Analysis of Published and Unpublished Cases at a Tertiary Care Hospital in North India.

Authors:  Ayush Gupta; Arnab Ghosh; Gagandeep Singh; Immaculata Xess
Journal:  Mycopathologia       Date:  2017-10-27       Impact factor: 2.574

3.  High 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report.

Authors:  Shigeaki Umeoka; Takashi Koyama; Tsuneo Saga; Tatsuya Higashi; Noriyuki Ito; Toshiyuki Kamoto; Hirokazu Kotani; Osamu Ogawa; Kaori Togashi
Journal:  Eur Radiol       Date:  2005-02-12       Impact factor: 5.315

Review 4.  Surgical management of adrenocortical tumours.

Authors:  Barbra S Miller; Gerard M Doherty
Journal:  Nat Rev Endocrinol       Date:  2014-03-18       Impact factor: 43.330

5.  Primary adrenal tuberculosis infection in patients with Behcet's disease presenting as isolated adrenal metastasis by 18F-FDG PET/CT: a rare case report and literature review.

Authors:  Qiliang Teng; Bo Fan; Yutong Wang; Shuang Wen; Honglong Wang; Tianqing Liu; Liang Wang
Journal:  Gland Surg       Date:  2021-12

6.  ADRENAL HISTOPLASMOSIS: AN EASTERN INDIAN PERSPECTIVE.

Authors:  S S Agrawal; P P Chakraborty; A Sinha; A Maiti; M Chakraborty
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

7.  Adrenal histoplasmosis: An unusual cause of adrenomegaly.

Authors:  S Vyas; N Kalra; P J Das; A Lal; S Radhika; A Bhansali; N Khandelwal
Journal:  Indian J Nephrol       Date:  2011-10

8.  18F FDG PET/CT identifies unsuspected bilateral adrenal histoplasmosis in an elderly immuno compromised patient.

Authors:  S Padma; Sreekala Sreehar
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

9.  Adrenal involvement in histoplasmosis.

Authors:  Norasyikin A Wahab; Rozita Mohd; Suehazlyn Zainudin; Nor Azmi Kamaruddin
Journal:  EXCLI J       Date:  2013-01-11       Impact factor: 4.068

Review 10.  Adrenal infections.

Authors:  William F Paolo; Joshua D Nosanchuk
Journal:  Int J Infect Dis       Date:  2006-02-17       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.